It is difficult to identify patients at risk of disease reactivation. So in a recent study scientists at Cerrahpasa School of Medicine, Istanbul University in Turkey compared the demographic and clinical features of patients experiencing severe disease reactivation (SDR) after Gilenya was stopped, with those of patients who did not...Read more - http://www.ms-uk.org/gilenya-withdrawal ... e-activity
